TERN icon

Terns Pharmaceuticals
TERN

Overview Fund Activity

45 hedge funds and large institutions have $134M invested in Terns Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
16
Increased
18
Reduced
8
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VA
VR Adviser
New York
$21.8M
2
VC
Vivo Capital
California
$34.7M
3
FFM
Fairmount Funds Management
Pennsylvania
$12.1M
4
DM
Deerfield Management
New York
$11M
5
DCM
Driehaus Capital Management
Illinois
$9.41M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
$0
2
SCM
Suvretta Capital Management
New York
$0
3
AC
Antara Capital
New York
$0
4
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
5
AAA
Affinity Asset Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
E
51
Ergoteles
New York
– -$157K -63,454 Closed
MAM
52
Marquette Asset Management
Minnesota
– -$144K -57,876 Closed
Citadel Advisors
53
Citadel Advisors
Florida
– -$96K -38,810 Closed
B
54
Bailard
California
– -$50K -20,300 Closed
PI
55
PEAK6 Investments
Illinois
– -$123K -14,097 Closed
CSS
56
Cubist Systematic Strategies
Connecticut
– -$6K -2,428 Closed
1 2
3